Company news

Remgro Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Remgro Enters Agreement To Restructure Interests In Mediclinic Group With IHL

March 31, 2026

REM: Earnings up 38.8% and interim dividend up 80%, with strong cash generation and portfolio gains

March 25, 2026

REM: HEPS expected to rise 36%–41% year-over-year for the six months ended 31 December 2025

March 13, 2026

Remgro Sells About 52 Million Additional Firstrand Shares

March 11, 2026

Remgro Says Negotiations On Potential Mediclinic Restructuring Ongoing

January 16, 2026

Remgro Says 1: 1 Equity Value Exchange Ratio Envisaged For Mediclinic And Hirslanden

December 1, 2025

REM: Headline earnings up 38.6%, dividends and cash flow surged, with strong portfolio performance

September 23, 2025

REM: Maziv's ZAR 36bn deal advances with regulatory support, major CapEx, and BEE commitments

July 21, 2025

REM: Portfolio now 63% private, with growth led by Mediclinic and CIVH, and focus on performance

April 14, 2025

REM: Headline earnings up 38.7%, dividend up 20%, and Heineken Beverages returns to profitability

March 25, 2025

REM: All resolutions passed as shareholders engaged on strategy, incentives, and global risks

November 28, 2024

REM: Headline earnings fell 20% and major impairments drove net profit sharply lower

September 19, 2024

Calls

The 5 newest of 7 calls. Every call is listed under its year.

Decks

The 5 newest of 25 decks. Every deck is listed under its year.